Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes
In conclusion, IL37 mRNA expression was down-regulated in AML patients, especially females, and those with the FAB M4 type and the WHO PML-RARA type. This expression may be affected by the immunophenotypic markers CD14 and HLA-DR.PMID:37716188 | DOI:10.1016/j.cyto.2023.156368
Source: Cytokine - Category: Molecular Biology Authors: Mustafa A Bashi Ali H Ad'hiah Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | France Health | Genetics | International Medicine & Public Health | Leukemia | Molecular Biology | Study | UK Health | WHO